跳至主要内容
临床试验/NCT01233661
NCT01233661撤回不适用

Short Atrioventricular Delay Pacing

University of Pittsburgh2 个研究点 分布在 1 个国家开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
serum biomarker concentrations

研究概览

简要总结

We intend to examine the effects of temporary elevation of atrial wall stress by shortening of the atrioventricular delay in patients with dual-chamber pacemakers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronically (i.e. implanted for at least six months) dual-chamber pacemaker
  • Stable cardiac status (i.e. no hospitalizations or cardiac medication changes within 3 months)
  • Ability to provide informed consent

排除标准

  • Age <18 years or >80 years
  • Pregnancy (if pregnancy is suspected, a urine pregnancy test will be performed)
  • Recent (within 12 months) left ventricular ejection fraction <50%
  • Significant valvular heart disease (mitral regurgitation of greater than mild severity, any degree of mitral stenosis, aortic stenosis or insufficiency of greater than mild severity)
  • Prior coronary artery bypass graft or valve surgery, recent (i.e. within 3 months) acute coronary syndrome or percutaneous coronary intervention, or chronic stable angina
  • History of clinically important atrial or ventricular tachyarrhythmias, defined as complex ventricular ectopy (i.e. couplets, triplets, or ventricular tachycardia), AF, atrial tachycardia, or other supraventricular tachycardias not cured with prior ablative therapy).
  • Significant chronic systemic inflammatory or neoplastic disease
  • Chronic renal or hepatic insufficiency. Renal insufficiency will be defined as a creatinine clearance of less than 20 cc/min. Evidence of hepatic insufficiency will consist of abnormal synthetic function (INR >1.4 without oral anticoagulant use, albumin < 3.0 mg/dL) or abnormal clearance function (total bilirubin >2.0).
  • Uncorrected thyroid abnormalities

结局指标

主要结局

serum biomarker concentrations

时间窗: 30 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验